MAGGIE DUKE: Open Payments
NPI 1942747266 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 7 payments from 3 companies in 2025. Trend: 2023 $88 · 2024 $206 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 4 | $174 |
| REVANCE THERAPEUTICS, INC. | 2 | $105 |
| Galderma Laboratories, L.P. | 1 | $26 |
Products named: Xeomin, DAXXIFY, DYSPORT.
Industry payments across MS — which companies pay providers there.
